Jesse Smith, NP
Primary Care · Athens, GANPI 1770942732
Payments from drug & device makers
Across 34 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$91
- Tandem Diabetes Care, Inc.$79
- Lilly USA, LLC$77
- Dexcom, Inc.$64
- Radius Health, Inc.$63
- Sanofi-aventis U.S. LLC$53
- plus $304 from 10 others
What the payments were for
- Food & beverage$730100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 4 | $91 |
| Tandem Diabetes Care, Inc. | 3 | $79 |
| Lilly USA, LLC | 4 | $77 |
| Dexcom, Inc. | 3 | $64 |
| Radius Health, Inc. | 2 | $63 |
| Sanofi-aventis U.S. LLC | 2 | $53 |
| Abbott | 2 | $42 |
| Almatica Pharma LLC | 2 | $39 |
| Bayer | 2 | $38 |
| Amgen | 2 | $36 |
| Exact Sciences | 2 | $33 |
| AbbVie | 2 | $30 |
| Medtronic | 1 | $26 |
| Corium, LLC | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$730 in reported general payments places this provider in the 60th percentile of 235 primary care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 47 | $426 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $381 |
| Rosuvastatin Calcium | 19 | $378 |
| Levothyroxine Sodium | 41 | $375 |
| Gabapentin | 20 | $312 |
| Lisinopril | 41 | $211 |
| Allopurinol | 19 | $183 |
| Trazodone Hcl | 22 | $172 |
| Duloxetine Hcl | 15 | $170 |
| Escitalopram Oxalate | 24 | $145 |
| Doxycycline Hyclate | 20 | $141 |
| Famotidine | 17 | $134 |
| Metformin Hcl | 34 | $128 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $128 |
| Losartan Potassium | 17 | $114 |
Paid to pharmacies, not to this prescriber.
Other primary care in Athens
- Kimberly PittmanAthens$5K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.